These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 15168633

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preventing stroke in patients with atrial fibrillation: current treatments and new concepts.
    Connolly SJ.
    Am Heart J; 2003 Mar; 145(3):418-23. PubMed ID: 12660663
    [Abstract] [Full Text] [Related]

  • 4. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Economides Muñoz C, Singh BN.
    Minerva Cardioangiol; 2004 Apr; 52(2):125-39. PubMed ID: 15194994
    [Abstract] [Full Text] [Related]

  • 5. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
    Albers GW, Yim JM, Belew KM, Bittar N, Hattemer CR, Phillips BG, Kemp S, Hall EA, Morton DJ, Vlasses PH.
    Arch Intern Med; 1996 Nov 11; 156(20):2311-6. PubMed ID: 8911237
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anticoagulation and atrial fibrillation.
    Atwood JE, Albers GW.
    Herz; 1993 Feb 11; 18(1):27-38. PubMed ID: 8454250
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation.
    Hammwöhner M, Goette A.
    J Cardiovasc Pharmacol; 2008 Jul 11; 52(1):18-27. PubMed ID: 18594479
    [Abstract] [Full Text] [Related]

  • 16. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.
    Peterson GM, Boom K, Jackson SL, Vial JH.
    Intern Med J; 2002 Jul 11; 32(1-2):15-23. PubMed ID: 11783668
    [Abstract] [Full Text] [Related]

  • 17. Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V).
    Halperin JL, Executive Steering Committee, SPORTIF III and V Study Investigators.
    Am Heart J; 2003 Sep 11; 146(3):431-8. PubMed ID: 12947359
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
    Agarwal S, Hachamovitch R, Menon V.
    Arch Intern Med; 2012 Apr 23; 172(8):623-31; discussion 631-3. PubMed ID: 22450212
    [Abstract] [Full Text] [Related]

  • 20. Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation.
    Lip GY, Frison L, Grind M, SPORTIF Investigators.
    J Intern Med; 2008 Jul 23; 264(1):50-61. PubMed ID: 18266660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.